Issuer · CIK 0001625297
INDV — Indivior Pharmaceuticals, Inc.
Recent filings
- Mar 13, 2026·Form 4·Buy$248.7
INDV/Indivior Pharmaceuticals, Inc.
Ryan Barbara · director
scoring - Mar 5, 2026·Form 4·Other$264.9K
INDV/Indivior Pharmaceuticals, Inc.
Anderson Woodrow D · Chief Accounting Officer
4conviction - Mar 5, 2026·Form 4·Other$2.8M
INDV/Indivior Pharmaceuticals, Inc.
Preblick Ryan · Chief Financial Officer
scoring